IDF23-0145 Once-weekly semaglutide in type 2 diabetes patients with heart failure with reduced left ventricular ejection fraction

Autor: Calero, A. Trenas, Pérez-Velasco, M.A., Sanz-Cánovas, J., Ricci, M., López-Sampalo, A., López-Carmona, M.D., Cobos-Palacios, L., Bernal-López, M.R., de Lucas, M.D. García, Jansen-Chaparro, S., Gómez-Huelgas, R., Pérez-Belmonte, L.M.
Zdroj: In Diabetes Research and Clinical Practice March 2024 209 Supplement 1
Databáze: ScienceDirect
Externí odkaz: